New Treatment Strategies in the Treatment of Juvenile Idiopathic Arthritis

İbrahim GÖKÇE, Erkan DEMİRKAYA

DOI: 10.5606/tjr.2011.012

Issue: Volume 26 - Issue 1 - January 2011
16817 6609

The Reported Adverse Effects Related to Biological Agents Used for the Treatment of Rheumatic Diseases in Turkey

Erkan KILIÇ, Gamze KILIÇ, Özgür AKGÜL, Gürkan AKGÖL, Salih ÖZGÖÇMEN

DOI: 10.5606/tjr.2013.3052

Issue: Volume 28 - Issue 3 - September 2013
12963 4296

The Off-Label Use of Rituximab for the Management of Inflammatory Disorders: American University of Beirut Medical Center Experience

Dana HARB, Hiba MOUKADEM, Rabih NAYFE, Ali MEHDI, Abdel Fattah MASRI, Ziad SALEM, Ali TAHER, Imad UTHMAN

DOI: 10.5606/ArchRheumatol.2014.3855

Issue: Volume 29 - Issue 3 - September 2014
9751 3872

Aortic Valve Involvement in a Patient With Granulomatosis With Polyangiitis

Gurmeet SINGH, Surinder Kumar BALI, Varsha KOUL

DOI: 10.5606/ArchRheumatol.2014.4006

Issue: Volume 29 - Issue 3 - September 2014
5777 3511

A Rare Kind of Lymphoma in a Patient on Treatment With Two Different Biological Agents

Inesa ARSTIKYTE, Irena BUTRIMIENE, Agne PETRULIONIENE, Algirdas VENALIS

DOI: 10.5606/ArchRheumatol.2015.4383

Issue: Volume 30 - Issue 1 - March 2015
7558 3824

Immunoglobulin G4-Related Disease Presented as Recurrent Otitis Media and Mixed Hearing Loss Treated With Cyclophosphamide and Rituximab: A Case Report

Shao SAN, Chia-der LIN, Sheng-ta TSAI, Chao-chun LIN, Po-chang WU

DOI: 10.5606/ArchRheumatol.2019.7178

Issue: Volume 34 - Issue 2 - June 2019
1049 1527

Efficacy of Rituximab for Refractory Pyoderma Gangrenosum-Like Ulcers in Granulomatosis With Polyangiitis Associated to Antiphospholipid Antibodies

Julia RIERA, Jorge MUSURUANA, Cecilia COSTA, Javier CAVALLASCA

DOI: 10.46497/ArchRheumatol.2020.7498

Issue: Volume 35 - Issue 3 - September 2020
812 1538